「Pneumococcus」の版間の差分
ナビゲーションに移動
検索に移動
Vaccipedia.admin (トーク | 投稿記録) |
Vaccipedia.admin (トーク | 投稿記録) |
||
6行目: | 6行目: | ||
*the leading cause of lower respiratory infections followed by ''H. influenzae'', influenza /B and RS virus | *the leading cause of lower respiratory infections followed by ''H. influenzae'', influenza /B and RS virus | ||
*50% of pneumococcal deaths in India, Nigeria, DRC and Pakistan | *50% of pneumococcal deaths in India, Nigeria, DRC and Pakistan | ||
+ | |||
+ | ==serotype== | ||
+ | *all serotypes known more than 90 are pathogenic for human | ||
+ | *differentiation of serotypes is important for epidemiology |
2021年5月31日 (月) 13:19時点における版
Navigation Menu | ![]() |
展開するGeneral issues of Vaccine |
---|
展開するGeneral issues of Tropical med. |
---|
展開するGeneral issues of Travel med. |
---|
展開するImmunology |
---|
展開するEpi & Stats |
---|
展開するVirus |
---|
展開するCOVID-19 |
---|
展開するBacteria |
---|
展開するRickettsia |
---|
展開するProtozoa |
---|
展開するFungi |
---|
展開するNematode (roundworm) |
---|
展開するTrematode (fluke, distoma) |
---|
展開するCestode (tapeworm) |
---|
展開するMedical Zoology |
---|
epidemiology
- 1.19mi. deaths in 2016
- 197.05 mil. episodes in 2016
- the leading cause of lower respiratory infections followed by H. influenzae, influenza /B and RS virus
- 50% of pneumococcal deaths in India, Nigeria, DRC and Pakistan
serotype
- all serotypes known more than 90 are pathogenic for human
- differentiation of serotypes is important for epidemiology